404 results
8-K
EX-3.1
LSTA
Lisata Therapeutics Inc
5 Jan 15
Departure of Directors or Certain Officers
12:00am
to the purpose or purposes stated in the notice of meeting.
1.4 Notice of Meetings. Except as otherwise provided by law, written notice of each meeting … stockholders and proxyholders may be deemed to be present in person and vote at such meeting and, in the case of a special meeting, the purpose or purposes
S-8 POS
LSTA
Lisata Therapeutics Inc
19 Aug 05
Registration of securities for employees (post-effective amendment)
12:00am
price per share is
estimated solely for the purpose of computing the amount of the registration fee
and is based on the average of the high and low … "), for the purpose of increasing the number of shares of common stock
to be issued under the Phase III Medical, Inc. 2003 Equity Participation Plan
8-K
EX-1.1
wt9z kmsmluxyp8aioh
16 Nov 10
NeoStem Announces Pricing of Concurrent
12:00am
8-K
EX-10.2
ghsu85vbzz4sowck1gu
25 Jan 21
Caladrius Biosciences Announces $25.0 Million Private Placement
4:01pm
S-8 POS
ougw1437 mk
24 May 07
Registration of securities for employees (post-effective amendment)
12:00am
8-K
EX-3.1
05179fj6758 iuzk
3 Oct 13
NeoStem Announces Proposed Public Offering of Common Stock
12:00am
8-K
EX-10.1
3qnn93kqgg32ve
27 Apr 22
Caladrius Biosciences and Cend Therapeutics Announce
7:05am
425
EX-1.1
ge4y6w
20 Jul 11
Business combination disclosure
12:00am
425
EX-1.2
eilcy0euga7l8tdu
16 Nov 10
Business combination disclosure
12:00am
425
EX-1.1
pykhqld
16 Nov 10
Business combination disclosure
12:00am
SC TO-T
nrjl0mu f3
15 Jul 09
Third party tender offer statement
12:00am
S-8
yy0sb
30 Jun 21
Registration of securities for employees
4:07pm